Skip to main content

Table 1 Demographic and clinical characteristics of women with PCOS in the three groups

From: Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: a pilot study

Variable

Poor responders (n = 7)

High responders (n = 14)

Normal responders (n = 14)

P value

PCOS phenotype according to NIH subclassification [2, 18]

 Phenotype 1

7

10

7

 Phenotype 2

0

0

0

 Phenotype 3

0

0

0

 Phenotype 4

0

4

7

Age (years)

31.43 ± 1.72

29.86 ± 4.13

30.29 ± 3.31

0.546

BMI (kg/m2)

29.07 ± 2.15

22.33 ± 3.39a

23.47 ± 3.76a

< 0.001

AFC

18.64 ± 1.21

14.36 ± 1.92ab

12.57 ± 0.85a

< 0.001

Basal FSH level (mIU/ml)

6.45 ± 1.78

6.76 ± 1.79

6.57 ± 1.25

0.904

Basal LH level (mIU/ml)

4.68 ± 2.08

7.17 ± 6.14

4.09 ± 1.80

0.147

Basal estradiol level (pg/ml)

45.86 ± 19.89

45.07 ± 19.93

40.57 ± 15.12

0.747

Basal progesterone level (ng/ml)

0.64 ± 0.28

0.68 ± 0.38

0.63 ± 0.60

0.965

PRL level (ng/ml)

14.64 ± 6.25

20.78 ± 10.92

16.92 ± 5.45

0.239

AMH level (ng/ml)

10.94 ± 3.80b

7.50 ± 4.92b

2.33 ± 2.08

< 0.001

Testosterone level before CPA treatment (ng/ml)

1.02 ± 0.30

0.69 ± 0.30c

0.57 ± 0.21a

0.003

Testosterone level after CPA treatment (ng/ml)

0.55 ± 0.14

0.61 ± 0.12

0.57 ± 0.21

0.722

No. of previous stimulated cycles

16

2

1

No. of previous canceled cycles

16

0

0

  1. Data are presented as mean ± SD. Statistical significance was defined as P < 0.05. “a” refers to P < 0.01, relative to poor responders. “b” refers to P < 0.01, relative to normal responders. “c” refers to P < 0.05, relative to poor responders